1. Andriukaitis V. European Rare Diseases Day 2018: One-year anniversary of the European Reference Networks for rare diseases. European Commission, Health and Food Safety Directorate General. 2018.
https://ec.europa.eu/ireland/news/european-rare-disease-day-2018_en
. Accessed 24 March 2018.
2. Le Cam Y. Inventory of Access and Prices of orphan drugs across Europe: a collaboration work between national alliances on rare diseases and Eurordis. 2010.
https://img2.eurordis.org/newsletter/pdf/mar-2011/ERTC_13122010_YLeCam_Final.pdf
. Accessed 07 Sep 2016.
3. Detiček A, Locatelli I, Kos M. Patient Access to Medicines for Rare Diseases in European Countries. Value in Health. 2018.
https://www.sciencedirect.com/science/article/pii/S109830151830189X
. Accessed 24 March 2018
4. Chaffotec AL. Trajectoires de soins et facteurs sociodémographiques : l’exemple des maladies rares en France, care path and sociodemographic attributes: the case of rare diseases in France. Journal de gestion et d'économie médicales. 2015;32(5):389–409.
5. Gridchyna I, Aulois-Griot M. La rétrocession de médicaments par les hôpitaux : quels bénéfices pour les acteurs ? Médecine Droit. 2011;110:203–10.